Compugen Ltd.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Compugen is a biotechnology company developing therapeutic solutions for cancer and autoimmune diseases.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 15:59 |
Regulatory News Service
Compugen to Present AI/ML Driven Predictive Computational Research at
Upcoming …
|
English | 92.7 KB | |
| 2025-06-12 15:59 |
Foreign Filer Report
Compugen to Present AI/ML Driven Predictive Computational Research at
Upcoming …
|
English | 36.3 KB | |
| 2025-05-19 16:00 |
Foreign Filer Report
Compugen Reports First Quarter 2025 Results
|
English | 157.5 KB | |
| 2025-05-19 16:00 |
Report Publication Announcement
Compugen Reports First Quarter 2025 Results
|
English | 36.2 KB | |
| 2025-05-13 16:00 |
Takeover Announcement Report
Leadership Transitions Effective September 2025
|
English | 484.4 KB | |
| 2025-05-13 16:00 |
Foreign Filer Report
Leadership Transitions Effective September 2025
|
English | 36.3 KB | |
| 2025-05-05 15:59 |
Earnings Release
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025, confere…
|
English | 89.2 KB | |
| 2025-05-05 15:59 |
Report Publication Announcement
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025, confere…
|
English | 36.3 KB | |
| 2025-03-26 14:00 |
Regulatory News Service
Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
|
English | 97.4 KB | |
| 2025-03-26 14:00 |
Foreign Filer Report
Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
|
English | 36.3 KB | |
| 2025-03-04 15:30 |
Foreign Filer Report
FORM 20-F- For the fiscal year ended December 31, 2024
|
English | 1.4 MB | |
| 2025-03-04 15:30 |
Foreign Filer Report
FORM 20-F- For the fiscal year ended December 31, 2024
|
English | 36.4 KB | |
| 2025-03-04 15:00 |
Earnings Release
Form 6-K- Fourth Quarter and Full Year 2024 Results
|
English | 1.4 MB | |
| 2025-03-04 15:00 |
Foreign Filer Report
Form 6-K- Fourth Quarter and Full Year 2024 Results
|
English | 36.4 KB | |
| 2025-03-03 15:00 |
Regulatory News Service
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global …
|
English | 94.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |